Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies

Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies

PURPOSEThe globalization of clinical trials has accelerated recent advances in multiple myeloma (MM). However, it is unclear whether trial enrollment locations are reflective of the global burden of MM and whether access to novel therapies is timely and equitable for countries that participate in th...

Full description

Bibliographic Details
Main Authors: Raleigh Ayoolu Fatoki, Kelly Koehn, Amar Kelkar, Samer Al Hadidi, Nikita Mehra, Hira Mian, Ola Landgren, Dickran Kazandjian, James Hoffman, Douglas W. Sborov, Ghulam Rehman Mohyuddin
Format: Article
Language:English
Published: American Society of Clinical Oncology 2022-08-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.22.00119

Similar Items

Similar Items